Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2010 1
2011 6
2012 6
2013 4
2014 11
2015 15
2016 10
2017 10
2018 7
2019 11
2020 8
2021 8
2022 3
2023 2
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, Borie R, Brillet PY, Cadranel J, Court-Fortune I, Crestani B, Debray MP, Gomez E, Gondouin A, Hirschi-Santelmo S, Israel-Biet D, Jouneau S, Juvin K, Leger J, Kerjouan M, Marquette CH, Naccache JM, Nunes H, Plantier L, Prevot G, Quetant S, Traclet J, Valentin V, Uzunhan Y, Wémeau-Stervinou L, Bejan-Angoulvant T, Cottin V, Marchand-Adam S; EVER-ILD investigators and the OrphaLung network. Mankikian J, et al. Among authors: bejan angoulvant t. Eur Respir J. 2023 Jun 8;61(6):2202071. doi: 10.1183/13993003.02071-2022. Print 2023 Jun. Eur Respir J. 2023. PMID: 37230499 Free article. Clinical Trial.
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.
Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, Johnson DB, Nohria A, Ben Zadok OI, Moslehi JJ, Salem JE; International ICI-Myocarditis Registry. Power JR, et al. Eur Heart J. 2025 Jun 18:ehaf315. doi: 10.1093/eurheartj/ehaf315. Online ahead of print. Eur Heart J. 2025. PMID: 40569849 Free article.
Information et communication sur les risques liés au médicament et son bon usage auprès des professionnels de santé et du public : principe de précaution, gestion du risque, communication pendant et en dehors des situations de crise.
Molimard M, Bernaud C, Lechat P; et les participants à la table ronde N°6 de Giens XXIX :; Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M. Molimard M, et al. Among authors: bejan angoulvant t. Therapie. 2014 Jul-Aug;69(4):355-60. doi: 10.2515/therapie/2014044. Therapie. 2014. PMID: 27393228 French. No abstract available.
[Drugs news].
Jonville-Béra AP, Bejan-Angoulvant T. Jonville-Béra AP, et al. Among authors: bejan angoulvant t. Arch Pediatr. 2013 Jan;20(1):82-8. doi: 10.1016/j.arcped.2012.10.016. Epub 2012 Nov 27. Arch Pediatr. 2013. PMID: 23199562 French. No abstract available.
[Endogenous and exogenous estrogens].
Bejan-Angoulvant T, Arnal JF. Bejan-Angoulvant T, et al. Presse Med. 2019 Nov;48(11 Pt 1):1244-1248. doi: 10.1016/j.lpm.2019.10.008. Epub 2019 Nov 12. Presse Med. 2019. PMID: 31732361 Review. French.
SGLT2 inhibitors: towards a personalized prescription.
de Freminville JB, Bejan-Angoulvant T. de Freminville JB, et al. Among authors: bejan angoulvant t. Eur J Prev Cardiol. 2025 Apr 15:zwaf220. doi: 10.1093/eurjpc/zwaf220. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40233196 No abstract available.
[Update on beta blockers in 2020].
Bejan-Angoulvant T, Angoulvant D. Bejan-Angoulvant T, et al. Rev Med Interne. 2020 Nov;41(11):741-747. doi: 10.1016/j.revmed.2020.04.007. Epub 2020 Jun 10. Rev Med Interne. 2020. PMID: 32532560 Review. French.
[Drugs news].
Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Béra AP. Vrignaud L, et al. Among authors: bejan angoulvant t. Arch Pediatr. 2017 Aug;24(8):783-787. doi: 10.1016/j.arcped.2017.05.008. Epub 2017 Jun 28. Arch Pediatr. 2017. PMID: 28668216 French. No abstract available.
[Drugs news].
Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Béra AP. Beau-Salinas F, et al. Among authors: bejan angoulvant t. Arch Pediatr. 2015 Apr;22(4):440-6. doi: 10.1016/j.arcped.2015.01.005. Epub 2015 Feb 26. Arch Pediatr. 2015. PMID: 25727471 French. No abstract available.
106 results